<?xml version="1.0" encoding="UTF-8"?>
<document id="DDI-DrugBank.d285">
    <sentence id="DDI-DrugBank.d285.s0" text="Reduced efficacy and increased incidence of breakthrough bleeding and menstrual irregularities have been associated with concomitant use of rifampin.">
        <entity id="DDI-DrugBank.d285.s0.e0" charOffset="140-147"
            type="drug" text="rifampin"/>
    </sentence>
    <sentence id="DDI-DrugBank.d285.s1" text="A similar association, though less marked, has been suggested with barbiturates, phenyl-butazone, phenytoin sodium, carbamazepine and possibly with griseofulvin, ampicillin, and tetracyclines (72)">
        <entity id="DDI-DrugBank.d285.s1.e0" charOffset="67-78"
            type="group" text="barbiturates"/>
        <entity id="DDI-DrugBank.d285.s1.e1" charOffset="98-113"
            type="drug" text="phenytoin sodium"/>
        <entity id="DDI-DrugBank.d285.s1.e2" charOffset="116-128"
            type="drug" text="carbamazepine"/>
        <entity id="DDI-DrugBank.d285.s1.e3" charOffset="148-159"
            type="drug" text="griseofulvin"/>
        <entity id="DDI-DrugBank.d285.s1.e4" charOffset="162-171"
            type="drug" text="ampicillin"/>
        <entity id="DDI-DrugBank.d285.s1.e5" charOffset="178-190"
            type="group" text="tetracyclines"/>
    </sentence>
    <sentence id="DDI-DrugBank.d285.s2" text="."/>
    <sentence id="DDI-DrugBank.d285.s3" text=""/>
    <sentence id="DDI-DrugBank.d285.s4" text=""/>
</document>
